Advances in the Care of Diabetes and Cancer

                              http://mathewsopenaccess.com/cancer-science-articlesinpress.html

At first glance, it may appear that diabetes and cancer are unrelated; However, as with other non-communicable diseases, the number of patients with diabetes and cancer is continuously increasing, especially in low- and middle-income countries; And according to recent studies, people with type 1 and type 2 diabetes are more commonly diagnosed with cancer - and are more likely to die of cancer - than people without diabetes. The relationship between the two diseases is stronger among certain types of cancer, including kidney, pancreatic, breast and colorectal cancer.

occur in developing countries. Cancer is among the leading causes of morbidity and mortality worldwide, with approximately 14 million cases and 8.2 deaths each year. The proportion of diagnosed cancers in low- and middle-income regions, such as Africa, Asia, South America, and Central America, is estimated to account for about 70% of all cases worldwide. Without early detection and timely diagnosis both patients with diabetes and those with cancer are at risk of being diagnosed at advanced stages, reducing their chances of managing the disease. Limited access to diagnostic tools and innovative and quality medicines is a very important barrier in reducing the increasing impact of diabetes and cancer in lowand middle-income countries.

Prevention and treatment of non-communicable diseases, such as cancer and diabetes, can only be achieved through the joint efforts of health professionals, governments and regulatory agencies, insurers and individuals themselves. The health industry also plays an important role in gaining better access to diagnostic tools and innovative treatments. We must be aware of this responsibility and commit ourselves to the constant search for new ways to transform health care and achieve great successes and better outcomes for patients in Latin America. There are certain pharmaceutical companies that are already working and research is under way to restore lost beta cells - which produce insulin and allow the body to regulate blood sugar levels - in patients with type 1 diabetes. The study is still in its early stages, but results suggest that an oral drug could help treat or cure type 1 diabetes.